Open Access<p>Pretreatment Apparent Diffusion Coefficient as a Predictor of Response to Transcatheter Arterial Chemoembolization Immediately Combined with Radiofrequency Ablation for Treatment of Solitary Large Hepatocellular Carcinoma</p>
Author(s) -
Jing Tang,
Fengyong Liu,
Hongjun Yuan,
Xin Li,
Xiangdong Tian,
Kan Ji,
Xueping Li,
Wei Wang
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s270470
Subject(s) - medicine , hepatocellular carcinoma , effective diffusion coefficient , radiofrequency ablation , transcatheter arterial chemoembolization , proportional hazards model , magnetic resonance imaging , nuclear medicine , radiology , diffusion mri , ablation , imaging biomarker
To evaluate whether the pretreatment apparent diffusion coefficient (ADC) measured with diffusion weighted imaging (DWI) of tumor can be used as an imaging biomarker for predicting prognosis in solitary large hepatocellular carcinomas (HCCs) treated with transcatheter arterial chemoembolization (TACE) immediately combined with radiofrequency ablation (RFA).